Navigation Links
FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
Date:6/1/2010

N®  that is devoid of surges, microsurges and has fewer testosterone escapes vs. leuprolide, represents a stride forward in the treatment of advanced prostate cancer and may affect outcomes," said Dr. Morote.

Presentation Highlights

Dr. Moul discussed the rationale for androgen deprivation therapy in prostate cancer, in that testosterone is essential for the growth and viability of prostate tumor cells.

Medical castration results in clinically meaningful benefits for men with differing states of prostate cancer.(1) GnRH agonists are a form of medical castration.  However, GnRH agonists initially cause testosterone surge that may last up to two weeks, may stimulate cancer growth, and may cause clinical flare in up to 63% of patients.(2) Testosterone reductions to castrate levels may take up to 30 days with GnRH agonists. Microsurges and testosterone breakthroughs may also result from LHRH agonist treatment.

Dr. Moul cited FIRMAGON® as an alternative and innovative approach for the treatment of advanced prostate cancer. FIRMAGON®  is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved for the treatment of advanced prostate cancer.  FIRMAGON reversibly binds to the GnRH receptors in the pituitary gland, immediately suppressing the secretion of the luteinizing hormone (LH), follicle-stimulating hormone (FSH), and subsequently, testosterone levels.(3-6) It causes more rapid medical castration and eliminates testosterone surge and microsurges without affecting the androgen receptor.  Unlike LHRH agonists, such as leuprolide, an established treatment for advanced prostate cancer, FIRMAGON® does not induce an initial testosterone surge.

Dr. Moul referenced a randomized Phase III pivotal trial of 610 prostate cancer patients, in which FI
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year
2. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010
3. Elbit Imaging Ltd. Announces First Quarter Results for 2010
4. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
5. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
6. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
7. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
8. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
9. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
10. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
11. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 Pepperl+Fuchs, a world leader ... Corporation, a leading provider of HART protocol devices. ... further extend its integrated solutions offerings and strengthen ... "We are pleased to add the MACTek ... Jim Bolin , Pepperl+Fuchs, executive vice president ...
(Date:8/31/2015)... , Aug. 31, 2015  Ascendant Solutions, Inc. ... today announced that its Healthcare subsidiary, Dougherty,s Holdings, has ... on the downtown square of Springtown, Texas ... than 35 years, this community-based pharmacy has provided retail ... of Springtown . The ...
(Date:8/31/2015)... 2015  Daktari Diagnostics today announced a collaboration with Merck, ... and Canada , to develop Daktari,s ... up to $8.5 million over the next 3.5 years, will ... regulatory approval of Daktari,s HCV test. The ... can detect low levels of virus directly in a single ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3
... grounds, direct programming is superior,to cloning as a ... Nov. 20 Two major scientific,papers published this ... way to,generate patient-matched human pluripotent stem cells without ... or human or animal eggs.,Research groups in Wisconsin ...
... 20 The following statement,was released today by ... the Elizabeth Glaser Pediatric AIDS Foundation:, "Four ... Relief,(PEPFAR) began funding treatment and prevention, today,s report ... remains a devastating worldwide,pandemic, we are beginning to ...
Cached Medicine Technology:Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 2Two Major Studies Show: Human Pluripotent Stem Cells without Cloning or Destroying Embryo 3New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need 2
(Date:9/1/2015)... ... 2015 , ... The premier online medical education company for ... in podiatric, surgical and wound care conferences . The Residency Education Summits ... at the podium and across the table during hands-on surgical and advanced wound ...
(Date:8/31/2015)... ... 01, 2015 , ... Spinal fusion surgery – which connects ... long, arduous recovery. However, today’s minimally invasive fusions achieve similar results as traditional ... muscle damage. These advantages of minimally invasive surgery redeem the procedure’s reputation, according ...
(Date:8/31/2015)... Oaks, CA (PRWEB) , ... August 31, 2015 ... ... recently been updated to include a wealth of information for specific translation services ... has great expertise and an incredible track record of successful work. , ITC ...
(Date:8/31/2015)... ... , ... In an article based on a reader’s question that ... of treating back pain caused by a disrupted disk by using steroids rather than ... function in patients suffering from a herniated disk, the level of pain that patients ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence in ... unique to the Lake Orion area. This program is one of the most ... weight management program will incorporate group fitness and nutritional consultations to help people ...
Breaking Medicine News(10 mins):Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2
... , MONDAY, Oct. 31 (HealthDay News) -- Jay Cuetara arrived ... was told a critical component of the chemo cocktail that ... was unavailable. Cuetara, 49, didn,t get treatment that ... His San Francisco hospital managed to procure the drug and ...
... scientists report that patients whose estrogen receptor (ER)-positive breast ... factor experience poor outcomes -- including increased mortality. The ... levels of this factor, the protein known as heat ... more aggressive than those with low levels. ...
... likely to be divorced, are cleverer and feel better, reveals a ... today with 30 years ago. "It,s time to start talking about ... number of elderly is rising worldwide, and it is estimated that ... of the century. At the same time, old age ...
... scientists at Tufts University will develop ultra-sensitive techniques at ... cancer earlier, and treat it with greater precision, through ... Defense Breast Cancer Research Program made to Tufts chemist ... provide "individuals who have a history of creativity, innovative ...
... FRANCISCO -- Birds are getting bigger in central California, and ... colleagues. Goodman uncovered the trend while working as a ... analyzing data from thousands of birds caught and released each ... Point Reyes National Seashore. The SF State scientists, working ...
... -- Doctors who listen to Mozart while performing colonoscopies ... Better detection of these so-called adenomatous polyps could save ... colorectal cancer are better than 90 percent if the ... that Mozart,s music can provide a significant short-term boost ...
Cached Medicine News:Health News:Obama Acts to Ease U.S. Drug Shortages 2Health News:Obama Acts to Ease U.S. Drug Shortages 3Health News:High levels of master heat shock protein linked to poor prognosis in breast cancer patients 2Health News:The new old age - today's pensioners are very different to yesterday's 2Health News:Fighting breast cancer early, one cell at a time 2Health News:Bigger birds in central California, courtesy of global climate change 2Health News:Bigger birds in central California, courtesy of global climate change 3Health News:Could Listening to Mozart Help Doctors Spot Colon Polyps? 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Potassium in serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Valproic Acid in human serum...
Medicine Products: